NumFin

New Nordic Healthbrands AB (publ)

Symbol: NNH.ST

STO

19.6

SEK

Market price today

  • -12.6719

    P/E Ratio

  • 0.0178

    PEG Ratio

  • 121.43M

    MRK Cap

  • 0.00%

    DIV Yield

New Nordic Healthbrands AB (publ) (NNH-ST) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for New Nordic Healthbrands AB (publ) (NNH.ST). Companys revenue shows the average of 331.684 M which is 0.066 % gowth. The average gross profit for the whole period is 197.25 M which is -0.002 %. The average gross profit ratio is 0.613 %. The net income growth for the company last year performance is 1.194 % which equals -1.053 % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of New Nordic Healthbrands AB (publ), we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.010. In the realm of current assets, NNH.ST clocks in at 229.957 in the reporting currency. A significant portion of these assets, precisely 13.813, is held in cash and short-term investments. This segment shows a change of 0.291% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 0.915, if any, in the reporting currency. This indicates a difference of -87.876% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 2.183 in the reporting currency. This figure signifies a year_over_year change of -0.404%. Shareholder value, as depicted by the total shareholder equity, is valued at 106.03 in the reporting currency. The year over year change in this aspect is -0.058%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 101.892, with an inventory valuation of 105.11, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 0.5. Account payables and short-term debt are 86.44 and 26.64, respectively. The total debt is 28.82, with a net debt of 15.01. Other current liabilities amount to 25.27, adding to the total liabilities of 143.03. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

53.8513.810.711.9
10.4
10.8
14.4
9.1
6.9
6.8
6
6.1
5.2
1.5
2.4
2.5
3.4

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

433.07101.9116.597
90.6
92.9
63.3
61.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

408.14105.1110.2116.5
80.7
80.4
65.1
50.9
51.6
46.9
35
30.6
31.1
26.9
27.4
37.2
42.9

balance-sheet.row.other-current-assets

54.399.102.8
2.6
5.5
77.5
73.2
62
63.9
45.8
40.1
38.8
43.9
39.4
42.4
39.6

balance-sheet.row.total-current-assets

949.46230237.3228.2
184.3
189.6
157
133.2
120.5
117.6
86.8
76.8
75.1
72.3
69.2
82
85.9

balance-sheet.row.property-plant-equipment-net

16.374.43.22.2
1.8
1.7
1.3
1.2
1.7
1.6
1.8
1.5
1.6
1.6
2.6
4.8
6.4

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

11.60.53.63
1.7
0.7
0
0
0.2
0.7
3
5.2
7.6
13.4
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

11.60.53.63
1.7
0.7
0
0
0.2
0.7
3
5.2
7.6
13.4
19.6
26.4
33.8

balance-sheet.row.long-term-investments

0.920.97.50.6
0.3
0.9
0
0
0
0
0
0
0
0
-19.6
-26.4
-33.8

balance-sheet.row.tax-assets

10.2310.274.2
3.3
4.2
3.8
3.6
4.4
4.3
4.6
5.7
5.8
5.1
7
5.1
3.7

balance-sheet.row.other-non-current-assets

33.433.1-70
0
0
0.6
0.7
0.8
1
4.4
1
1.6
2.1
24
33.1
35.7

balance-sheet.row.total-non-current-assets

72.5519.114.310.1
7.2
7.5
5.6
5.6
7.1
7.6
13.8
13.5
16.6
22.2
33.7
42.9
45.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

1022249.1251.7238.4
191.5
197.2
162.6
138.8
127.6
125.2
100.7
90.3
91.7
94.6
102.9
125
131.7

balance-sheet.row.account-payables

324.3186.466.566
56
54.3
48.2
45.8
36.2
48.9
41.7
48.6
54.8
51.5
50
58.7
61.4

balance-sheet.row.short-term-debt

135.7226.648.324.4
1.6
10
2.7
7.3
29
18.1
9.4
9.5
9.8
13.9
10.8
11.7
12.4

balance-sheet.row.tax-payables

10.2721.73.6
2.7
5.5
3.5
1.5
2.2
2.3
1.7
0.5
2
1.9
5.3
6.2
6.4

balance-sheet.row.long-term-debt-total

8.222.21.60
0
1.9
1.1
1.4
1.3
1.3
1.2
0.8
0
0.8
4.7
10.2
15.5

Deferred Revenue Non Current

-0.27000
0
-1.9
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.94---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

66.6125.322.67.6
15.7
13
24.4
13.2
9.1
9.9
13.1
10.4
9.9
6.6
9.2
11.4
5.8

balance-sheet.row.total-non-current-liabilities

9.162.81.63.4
5
4.7
3.7
3.4
2.8
2.6
2.8
2.3
2.1
4.7
10.3
16.8
25.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

583.3143139.1118
86.7
95.3
82.4
78
84.6
89.5
75.6
76.7
83.3
82.9
91.5
110.1
122.7

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

24.786.26.26.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2

balance-sheet.row.retained-earnings

300.0796.8106.4114.1
98.6
95.7
74
54.6
36.8
29.6
13.6
3.4
-0.9
2.4
-5.7
0.9
-14.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

413.9299.8106.40.5
98.6
95.7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-300.07-96.8-106.4-0.5
-98.6
-95.7
0
0
0
0
5.2
3.9
3.2
3.1
11
7.7
17.3

balance-sheet.row.total-stockholders-equity

438.7106112.6120.3
104.8
101.9
80.2
60.8
43
35.8
25.1
13.5
8.5
11.6
11.4
14.8
9.1

balance-sheet.row.total-liabilities-and-stockholders-equity

1022249.1251.7238.4
191.5
197.2
162.6
138.8
127.6
125.2
100.7
90.3
91.7
94.6
102.9
125
131.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

438.7106112.6120.3
104.8
101.9
80.2
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

1022---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

9.570.97.50.6
0.3
0.9
0
0
0
0
0
0
0
0
-19.6
-26.4
-33.8

balance-sheet.row.total-debt

143.9428.848.324.4
1.6
11.8
3.8
8.7
30.3
19.4
10.6
10.3
9.8
14.7
15.5
21.9
27.9

balance-sheet.row.net-debt

90.091537.612.5
-8.8
1
-10.6
-0.4
23.5
12.6
4.6
4.2
4.6
13.2
13.1
19.4
24.5

Cash Flow Statement

The financial landscape of New Nordic Healthbrands AB (publ) has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 2.356. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 24.01 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -3396000.000 in the reporting currency. This is a shift of 0.297 from the previous year. In the same period, the company recorded 1.22, -0.33, and -21.17, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 0, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

-8.61-6.2-4.728.5
23.8
36.3
34.2
27.7
13
15.7
16.2
9.2
-1
6
0.2
6
-15.6

cash-flows.row.depreciation-and-amortization

2.031.21.60.9
0.8
0.6
0.7
0.8
1.1
2.9
2.9
3
6.5
8.1
8
9.3
8.4

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

14.8731.7-3.4-31.1
4.6
-31.1
-12
3.3
-7
-18
-12
-10
4.5
-3.4
2.4
-1.7
7.1

cash-flows.row.account-receivables

-3.852.8-10.4-4.6
6.1
-21.2
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-12.044.96.3-35.8
-0.3
-15.3
-14.2
0.7
-4.5
-13.5
-3.1
-1.4
-4.6
0.8
9.2
5.5
0.8

cash-flows.row.account-payables

30.77240.89.3
-1.2
5.3
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0.66000
0
0
2.2
2.6
-2.5
-4.4
-8.9
-8.7
9.1
-4.1
-6.8
-7.2
6.3

cash-flows.row.other-non-cash-items

-1.291.3-9-6.2
-9.5
-6.4
-5.1
-5.3
-5.4
-3.2
-4
-1.7
-5.8
-9.9
-8.6
-3.2
5

cash-flows.row.net-cash-provided-by-operating-activities

5.48000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-3.16-3.1-3-2.7
-1.9
-1.7
-0.9
-0.2
-0.6
-0.8
-0.6
-0.5
-0.9
-0.9
-0.8
-0.9
-1.8

cash-flows.row.acquisitions-net

000.30
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0.3
0
0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0.11-0.30-0.3
0.7
-0.4
0.3
0.1
0.6
2.9
-1.6
0.5
0.6
2.4
2.6
-4.8
-5.3

cash-flows.row.net-cash-used-for-investing-activites

-3.05-3.4-2.6-3
-1.2
-1.7
-0.5
0
0
2.1
-2.2
0
-0.3
1.5
1.9
-5.7
-7.1

cash-flows.row.debt-repayment

-28.42-21.2-24.3-22.9
-7.6
-8
-0.2
0
-0.3
0
0
0
0
0
-3.9
0
0

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-7.7-9.3
-10.8
-9.3
-7.1
-2.5
-1.5
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-7.01048.744.2
0.9
16.1
-4.6
-21.7
0
1.6
-1.5
0.4
-0.2
-3.3
0
-5.5
0.8

cash-flows.row.net-cash-used-provided-by-financing-activities

-3.96-21.216.612.1
-18.4
-1.2
-12
-24.2
-1.8
1.6
-1.5
0.4
-0.2
-3.3
-3.9
-5.5
0.8

cash-flows.row.effect-of-forex-changes-on-cash

-0.14-0.30.30.3
-0.5
0.1
0
-0.1
0.2
-0.2
0.4
0
-0.1
0
-0.1
0
0

cash-flows.row.net-change-in-cash

-1.683.1-1.21.5
-0.4
-3.6
5.3
2.2
0
0.8
-0.1
0.9
3.6
-0.9
0
-0.9
-1.5

cash-flows.row.cash-at-end-of-period

53.8513.810.711.9
10.4
10.8
14.4
9.1
6.9
6.8
6
6.1
5.2
1.5
2.4
2.5
3.4

cash-flows.row.cash-at-beginning-of-period

55.5310.711.910.4
10.8
14.4
9.1
6.9
6.8
6
6.1
5.2
1.5
2.4
2.5
3.4
4.9

cash-flows.row.operating-cash-flow

5.4828-15.5-7.9
19.7
-0.7
17.9
26.4
1.6
-2.6
3.2
0.5
4.2
0.9
2
10.4
4.9

cash-flows.row.capital-expenditure

-3.16-3.1-3-2.7
-1.9
-1.7
-0.9
-0.2
-0.6
-0.8
-0.6
-0.5
-0.9
-0.9
-0.8
-0.9
-1.8

cash-flows.row.free-cash-flow

2.3125-18.4-10.6
17.8
-2.4
17
26.2
1
-3.4
2.6
0
3.3
0
1.3
9.5
3.1

Income Statement Row

New Nordic Healthbrands AB (publ)'s revenue saw a change of 0.095% compared with the previous period. The gross profit of NNH.ST is reported to be -2.49. The company's operating expenses are 0.67, showing a change of -99.792% from the last year. The expenses for depreciation and amortization are 1.22, which is a -0.556% change from the last accounting period. Operating expenses are reported to be 0.67, which shows a -99.792% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.334% year-over-year growth. The operating income is -3.17, which shows a -0.334% change when compared to the previous year. The change in the net income is 1.194%. The net income for the last year was -6.19.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

537.81533.8487.5514.8
450.1
452.6
393.7
344.7
305.8
298.5
271.9
228
203.8
199.5
195.3
225.6
201.2

income-statement-row.row.cost-of-revenue

370.92536.3169164.8
141
137
116.2
112.5
106.3
101.8
98.2
79.2
77.3
73.9
72.4
95
70.1

income-statement-row.row.gross-profit

166.89-2.5318.5350
309.1
315.6
277.5
232.3
199.6
196.7
173.7
148.8
126.5
125.6
122.9
130.6
131.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0.67---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

139.45---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00323.256.7
47.5
46.3
41.2
36.2
36.1
34.6
31.3
29.4
33
33.8
34.5
39.8
50

income-statement-row.row.operating-expenses

360.460.7323.2321.5
285.2
279.3
243.3
204.6
186.6
181
157.5
139.6
127.5
119.6
122.7
124.7
146.7

income-statement-row.row.cost-and-expenses

546.99537492.3486.3
426.2
416.3
359.5
317.1
292.8
282.8
255.8
218.8
204.8
193.5
195.1
219.6
216.8

income-statement-row.row.interest-income

0.720.100
0
0
0
0
0
0.3
0.3
0.3
0.4
0.3
0
0
0

income-statement-row.row.interest-expense

2.612.81.50.6
0.5
0.4
0.3
0.6
0.8
1.2
1.7
2.7
3.3
3.1
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-2.07-2.8-0.4-0.6
-0.5
-0.2
-0.1
-0.5
-0.5
-1.5
0.3
-1.3
-3.5
-3.6
-4.7
-5.2
-1.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00323.256.7
47.5
46.3
41.2
36.2
36.1
34.6
31.3
29.4
33
33.8
34.5
39.8
50

income-statement-row.row.total-operating-expenses

-2.07-2.8-0.4-0.6
-0.5
-0.2
-0.1
-0.5
-0.5
-1.5
0.3
-1.3
-3.5
-3.6
-4.7
-5.2
-1.7

income-statement-row.row.interest-expense

2.612.81.50.6
0.5
0.4
0.3
0.6
0.8
1.2
1.7
2.7
3.3
3.1
0
0
0

income-statement-row.row.depreciation-and-amortization

2.031.22.80.9
0.8
0.7
0.7
0.8
1.1
2.9
2.9
3
6.5
8.1
8
9.3
8.4

income-statement-row.row.ebitda-caps

-7.15---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-9.19-3.2-4.728.5
23.8
36.3
34.2
27.7
13
15.7
16.2
9.2
-1
6
0.2
6
-15.6

income-statement-row.row.income-before-tax

-11.26-5.9-5.228
23.3
36.1
34.1
27.1
12.5
14.2
16.5
7.9
-4.6
2.4
-4.5
0.8
-17.3

income-statement-row.row.income-tax-expense

-1.090.3-2.36.7
5.5
8
7.6
6.8
2.9
2.9
4.2
2.1
-0.5
2.1
1.2
-0.1
-2.9

income-statement-row.row.net-income

-10.17-6.2-2.821.3
17.8
28.1
26.5
20.3
9.6
11.3
12.4
5.8
-4.1
0.3
-5.7
0.9
-14.4
Similar Stocks
You may also be interested in:
SNAX
Stryve Foods, Inc..
1.4 USD
NASDAQ
0809.HK
Global Bio-chem Technology Group Company Limited.
0.092 HKD
HKSE
072710.KS
Nongshim Holdings Co.,Ltd..
66900 KRW
KSC
8362.HK
Winning Tower Group Holdings Limited.
0.07 HKD
HKSE
AVIX
Avix Technologies, Inc..
0.0001 USD
PNK
SCPL.NS
Sheetal Cool Products Limited.
418.25 INR
NSE
2226.HK
Honworld Group Limited.
0.43 HKD
HKSE
HCT.AX
Holista Colltech Limited.
0.01 AUD
ASX
SOVO
Sovos Brands, Inc..
22.98 USD
NASDAQ

Frequently Asked Question

What is New Nordic Healthbrands AB (publ) (NNH.ST) total assets?

New Nordic Healthbrands AB (publ) (NNH.ST) total assets is 249060000.000.

What is enterprise annual revenue?

The annual revenue is 272769000.000.

What is firm profit margin?

Firm profit margin is 0.310.

What is company free cash flow?

The free cash flow is 0.373.

What is enterprise net profit margin?

The net profit margin is -0.019.

What is firm total revenue?

The total revenue is -0.017.

What is New Nordic Healthbrands AB (publ) (NNH.ST) net profit (net income)?

The net profit (net income) is -6194000.000.

What is firm total debt?

The total debt is 28824000.000.

What is operating expences number?

The operating expences are 672000.000.

What is company cash figure?

Enretprise cash is 9865000.000.